Drug Profile
Hydromorphone intranasal
Alternative Names: Intranasal hydromorphone HClLatest Information Update: 08 Oct 2021
Price :
$50
*
At a glance
- Originator Intranasal Therapeutics
- Developer Ikano Therapeutics
- Class Morphine derivatives; Opioid analgesics; Small molecules
- Mechanism of Action Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 22 Aug 2005 Intranasal Technology is now called Intranasal Therapeutics
- 24 Aug 2004 Phase-II clinical trials in Pain in USA (Intranasal)